{
  "context": {
    "rules": [
      "Rule1: Provided that the drug manufacturer uses raw material, it is not the case that the drug manufacturer produces drug formulation.",
      "Rule2: Either the drug formulation requires clinical trial, or if the failure of the implication that the worker having quality control skill results in the drug formulation being safe entails that contamination does not cause disease outbreak, then impurity does not cause adverse reaction.",
      "Rule3: Under the condition that the drug formulation is approved by the regulatory agency, the drug formulation does not require clinical trial.",
      "Rule4: Whenever the drug formulation passes the safety test, the drug formulation is approved by the regulatory agency.",
      "Rule5: The drug formulation passes the safety test or the drug formulation passes the efficacy test.",
      "Rule6: If the drug formulation is ordered by the distributor, then the drug formulation is shipped to the pharmacy.",
      "Rule7: If the drug formulation is delivered to the hospital, then the drug formulation is in stock at the warehouse.",
      "Rule8: Whenever the distributor has a contract with the hospital, then if the drug formulation is shipped to the pharmacy, the drug formulation is delivered to the hospital.",
      "Rule9: The facility has the certification for GMP compliance or the facility has the certification for ISO 9001.",
      "Rule10: Under the condition that the facility has the certification for ISO 9001, then if the manufacturing process complies with GMP standards, the drug formulation is safe.",
      "Rule11: Provided that the facility is audited by the regulatory agency, the certification is renewed through annual review.",
      "Rule12: The drug manufacturer has the processing machine as equipment, or if the drug manufacturer uses raw material, then the drug manufacturer produces drug formulation.",
      "Rule13: If the raw material has the defect of contamination, then it is not the case that the drug manufacturer has the processing machine as equipment.",
      "Rule14: The raw material has the defect of contamination or the raw material has the defect of impurity.",
      "Rule15: Provided that the raw material has the defect of impurity, then the drug manufacturer does not have the processing machine as equipment.",
      "Rule16: Either the worker has the skill of quality control or the worker has the skill of production technique.",
      "Rule17: If the worker has the skill of production technique, then the drug formulation is safe.",
      "Rule18: Provided that it is not the case that if the drug formulation passes the efficacy test, then the drug formulation is approved by the regulatory agency, the drug formulation receives fast track.",
      "Rule19: Under the condition that it is not the case that if the drug formulation passes the efficacy test, then the drug formulation is approved by the regulatory agency, the drug formulation does not receive fast track.",
      "Rule20: If it is not the case that if the certification is renewed through annual review, then provided that the facility has the certification for GMP compliance, then under the condition that the manufacturing process complies with GMP standards, the drug formulation is safe, then the facility receives a warning letter.",
      "Rule21: Provided that it is not the case that if the certification is renewed through annual review, then if the facility has the certification for GMP compliance, then under the condition that the manufacturing process complies with GMP standards, the drug formulation is safe, then the facility does not receive a warning letter.",
      "Rule22: Under the condition that it is not the case that if the worker has the skill of quality control, then the drug formulation is safe, contamination causes disease outbreak.",
      "Rule23: Provided that it is not the case that the failure of the implication that the worker having quality control skill results in the drug formulation being safe entails that contamination does not cause disease outbreak, impurity causes adverse reaction.",
      "Rule24: If the drug formulation is not safe, then the drug manufacturer uses raw material.",
      "Rule25: If the drug formulation is not safe, then the drug formulation is ordered by the distributor."
    ],
    "facts": [
      "Fact1: The distributor has a contract with the hospital.",
      "Fact2: The manufacturing process complies with GMP standards.",
      "Fact3: The facility is audited by the regulatory agency.",
      "Fact4: The drug formulation is not in stock at the warehouse."
    ]
  },
  "question": "The drug formulation is safe."
}